SRGAP2 and neoplasm: The expression of nine proteins (CD109, GNG4, MAPT, OSBPL3, PLXNA1, ROBO1, SLC16A3, SLC26A6, SRGAP2, and TMEM65) in LIHC cancer were higher in tumor tissues (81.82%) than in normal tissues (Figure 8).